Increased Levels of CHI3L1 and HA Are Associated With Higher Occurrence of Liver Damage in Patients With Obstructive Sleep Apnea
Authors:
Open Access
- 25 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 854570
Abstract
Background: Obstructive sleep apnea-hypopnea syndrome (OSA) may cause liver fibrosis, and liver fibrosis serum biomarkers plays an important role on the diagnosis of liver fibrosis. In addition, this study aimed to observe the changes of 4 serum markers and Chitinase 3-like protein 1 (CHII3L1) levels in OSA patients with different disease severity and explore their interactions. And then, we examined whether intermittent hypoxia (IH) exposure can activate hepatic stellate cell.Methods: 74 OSA patients in Second Xiangya hospital from January 2021 to October 2021 was selected and categorized into mild, moderate, and severe groups according to AHI. In addition, 20 subjects were selected as the control group. Serum levels of liver fibrosis markers were determined by electrochemiluminescence immunoassay. Hepatic stellate cells were exposed to intermittent IH or normoxia (RA). Results were analyzed using the SPSS software.Results: There was a significant increase in serum hyaluronic acid (HA), collagen type IV (CIV) and CHI3L1 levels in OSA patients compared with control group. Specifically, serum liver fibrosis markers HA, CIV and CHI3L1 levels were positively correlated with apnea-hypopnea index (AHI), but negatively correlated with the lowest saturation oxygen (LSaO2) respectively. The LX-2 cells (human hepatic stellate cell line) exposed to IH showed significant increases in fibrotic protein expression.Conclusion: OSA might either directly or indirectly trigger or exacerbate liver fibrosis, possibly via IH-related pathways.Keywords
This publication has 26 references indexed in Scilit:
- Obstructive sleep apnea is associated with liver disease: a population-based cohort studySleep Medicine, 2015
- Obstructive sleep apnea is an important predictor of hepatic fibrosis in patients with nonalcoholic fatty liver disease in a tertiary care centerHepatology International, 2015
- Management of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of PhysiciansAnnals of Internal Medicine, 2013
- Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obeseJournal of Hepatology, 2012
- A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infectionJournal of Hepatology, 2009
- Chronic intermittent hypoxia predisposes to liver injury†Hepatology, 2007
- Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities: Fig. 1—European Respiratory Journal, 2006
- Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infectionLiver International, 2006
- Excess weight and sleep-disordered breathingJournal of Applied Physiology, 2005
- Role of the measurement of serum procollagen type III N-terminal peptide in the evaluation of liver diseasesClinica Chimica Acta, 1994